Study Conduct

Japan's CROee, BBK Worldwide launch U.S. based BBK + CROee

Tuesday, June 17, 2014 10:06 AM

BBK Worldwide, a clinical trial marketing firm, and CROee, the first consulting Japanese CRO specializing in patient recruitment, have created a jointly-owned U.S.-based company, BBK + CROee.

More... »


BioClinica acquires Blueprint Clinical to boost presence in risk-based monitoring

Monday, June 16, 2014 09:21 AM

By Ronald Rosenberg
CenterWatch Staff Writer

In the scramble to harness technology to implement risk-based monitoring (RBM) strategies, BioClinica, a provider of technology-enhanced clinical trial management solutions, is acquiring Blueprint Clinical, a small Washington-based developer of Compass, a specialized software program that evaluates potential risks to patient safety and clinical trial operational performance.

More... »


DrugDev establishes DrugDev Innovation Lab, partners with two technology firms

Thursday, June 12, 2014 01:43 PM

DrugDev, a provider of technology-driven solutions that help investigators, sponsors and CROs conduct more trials together, has established the DrugDev Innovation Lab, a technology incubator designed to accelerate emerging solutions in clinical trial automation.

More... »

Boston Scientific initiates RESPOND post-market registry

Friday, June 6, 2014 12:56 PM

Boston Scientific, a global medical technology company, has initiated the RESPOND Post Market Registry to assess real-world performance of the Lotus Valve System. The RESPOND registry will collect data on clinical outcomes and device performance in 1,000 patients implanted at 50 centers around the world.

More... »

Report: Public perceptions of clinical trials have improved

Wednesday, June 4, 2014 01:16 PM

inVentiv Clinical Trial Recruitment Solutions (iCTRS), in collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP), has released results of research showing public perceptions of clinical trials have improved—good news for companies hoping to recruit for a trial.

More... »

Eli Lilly increases access to clinical trials data for qualified researchers

Monday, June 2, 2014 01:10 PM

Eli Lilly will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. This web site, which houses data from several trial sponsors, was created in support of ongoing efforts by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) to increase access to and transparency of clinical trial results with researchers around the world.

More... »

Medidata, TransCelerate BioPharma form joint initiative

Wednesday, May 28, 2014 01:05 PM

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, is partnering with TransCelerate BioPharma on a project designed to inform the nonprofit organization's continued efforts to modernize and streamline the way clinical trials are conducted and monitored worldwide.

More... »

Report: BRIC nations emerging as leaders in global trial landscape

Wednesday, May 28, 2014 12:49 PM

BRIC nations, including Brazil, Russia, India and China, are emerging leaders in the global clinical trials landscape, according to the Thomson Reuters report, Overcoming Clinical Challenges in BRIC Markets, which explores the benefits and challenges of conducting clinical trials in the pharmaceutical markets of the BRIC nations.

More... »

INC Research, SCRS partner

Wednesday, May 28, 2014 12:44 PM

CRO INC Research has announced a two-year partnership with the Society for Clinical Research Sites (SCRS), a global trade organization dedicated to representing the interests of clinical research sites. INC Research will participate as a Global Impact Partner (GIP), the highest level of membership within SCRS.

More... »

StemCells trial injecting cells into eye to treat AMD

Wednesday, May 28, 2014 11:37 AM

By Ronald Rosenberg
CenterWatch Staff Writer

In a closely-watched clinical trial, StemCells said it has transplanted the company’s purified human neural stem cells into the first five patients in the final cohort of its 16-patient phase I/II trial for the advanced or dry form of age-related macular degeneration (AMD). 

More... »

CenterWatch
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs